Parametry
- 238 stránek
- 9 hodin čtení
Více o knize
The 45th edition of the leading reference on treatment of infectious diseases and anti-infective drug information. Available in print in pocket size, spiral bound and large library editions. New material and areas of significant change in this 45th edition include: * HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for interferon-free therapy based on the latest guidelines. * Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated. * Antiretroviral therapy (Table 14): New once daily single tablet regimens have been added. * Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have been extensively updated. * Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new agents for treatment of resistant S. aureus. -- Publisher
Nákup knihy
The Sanford guide to antimicrobial therapy 2015, Kolektiv autorů
- Jazyk
- Rok vydání
- 2015
- product-detail.submit-box.info.binding
- (měkká)
Doručení
Platební metody
Tady nám chybí tvá recenze.
- Titul
- The Sanford guide to antimicrobial therapy 2015
- Jazyk
- anglicky
- Autoři
- Kolektiv autorů
- Rok vydání
- 2015
- Vazba
- měkká
- Počet stran
- 238
- ISBN10
- 1930808844
- ISBN13
- 9781930808843
- Série
- Štítky
- Naučná literatura, Učebnice, Zdraví & Lékařství, Lékařství, Příručky a návody, Lékařská tématika
- Hodnocení
- 4,45 z 5
- Anotace
- The 45th edition of the leading reference on treatment of infectious diseases and anti-infective drug information. Available in print in pocket size, spiral bound and large library editions. New material and areas of significant change in this 45th edition include: * HCV treatment (Table 14G): Expanded treatment options using the newest direct acting agents (DAA) for interferon-free therapy based on the latest guidelines. * Parasitic diseases (Table 13A): Treatment of parasitic diseases has been comprehensively updated. * Antiretroviral therapy (Table 14): New once daily single tablet regimens have been added. * Antibacterial drug information (Table 9, Table 10): Pharmacology data and adverse effects summary have been extensively updated. * Resistant Bacteria (Tables 1, 5, & 6): Updates reflect the latest data and treatment options, including new agents for treatment of resistant S. aureus. -- Publisher